European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Kent Featured PhD Programmes
Brunel University London Featured PhD Programmes
Karlsruhe Institute of Technology Featured PhD Programmes
"animal" AND "disease"×
10 miles

animal disease PhD Projects, Programs & Scholarships

We have 78 animal disease PhD Projects, Programs & Scholarships

  • "animal" AND "disease" ×
  • clear all
Order by 
Showing 1 to 10 of 78
  PhD position on dynamic modelling of animal behaviours using machine learning, intelligent sensors and computational ethology
  Dr T Norton
Applications accepted all year round
The laboratory of Measure, Model, Manage Bio-Responses (M3-BIORES) is a world-leading research laboratory focussing on real-time monitoring and management of animal behaviours.
  Disease phenomics - quantifying the development of disease symptoms in infected plants
  Dr S A Rolfe
Applications accepted all year round
Biology is undergoing a revolution as ‘omic technologies allow us to make hundreds or thousands of measurements on large populations of plants.
  Inter-species transmission of Mycobacterium Avium Paratuberculosis (MAP) sheep and beef cattle farming systems – understanding risk factors and impact on livestock productivity.
  Dr P Davies, Prof N Williams
Application Deadline: 15 April 2019
A fantastic opportunity for a self-motivated person to be at the forefront of researching an emerging ‘iceberg’ animal disease of sheep and cattle.
  Developing alternatives to antibiotics in UK pig production – the efficacy and mechanism of action of marine sulphated polysaccharides
  Dr G Pearce, Dr M Holmes
Application Deadline: 28 April 2019
Project Background. The use of antibiotics has played a major role in improving the health status, welfare and productivity of pig production over the last 50 years.
  Understanding disease mechanisms of Alzheimer’s disease
  Dr X Shu, Dr G Hunter
Application Deadline: 15 April 2019
Project reference number. SHLS19028. Alzheimer’s disease (AD) is the most common cause of dementia and is a growing global health concern in the world.
  Development of Gene Therapy and Gene Editing for Lung Disorders: the translation of new gene therapies to the clinic, including the development of new vectors, and evaluation in animal models of disease.
  Dr D Gill, Dr S Hyde
Application Deadline: 26 July 2019
The Gene Medicine Research Group is based in the John Radcliffe Hospital and is focused on the development of new gene therapeutics for lung diesases.
  Exploring aberrant inflammasome activation in chronic granulomatous disease
  Dr S Webster, Prof C E Bryant
Applications accepted all year round
This project will test the hypothesis. Aberrant inflammasome activation can be caused by mitochondrial ROS mediated NLRP3 inflammasome activation.
  MRC Precision Medicine DTP: 3D modelling of changes in genome architecture in development and disease
  Research Group: Institute of Cell Biology
  Prof E Schirmer, Dr D Marenduzzo
Application Deadline: 8 April 2019
Background. Defects in spatial genome organisation have recently been linked to human disease and the National Institutes of Health, USA director speculated that most as yet unidentified disease alleles will occur in non-coding genome regions.
  Investigating the link between amyloid-β oligomers, neuroinflammation and cognitive deficits in preclinical models for Alzheimer’s Disease
  Dr M Harte, Prof J Neill
Applications accepted all year round
Currently four out of the five pharmacological treatments used for Alzheimer’s disease (AD) are acetylcholinesterase inhibitors aimed at boosting the amount of acetylcholine in the brain, with the fifth being an N-methyl-D-aspartate (NMDA) receptor antagonist.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.